At the Estonian Genome Centre, the geneticist and her team are investigating the impact of genetic variations on drug metabolism and adherence to prescriptions.
The Estonian Genome Centre at the University of Tartu is one of the largest biobanks in Europe, containing biological samples and personal health information volunteered by more than 150,000 people, over 20% of the country’s adult population. This trove of data and materials is emblematic of Estonia’s ambitious personalized medicine programme and drive to be one of the world’s most advanced digital societies. It is a resource for genome-wide association studies to identify genetic variations linked with disease detection, treatment and prevention.
At the heart of the Estonian initiative is geneticist Lili Milani, group leader in pharmacogenomics at the biobank and one of the leading biomedical researchers by article count in the Nature Index.
Read the full article in Nature Index 2019 Biomedical Sciences with Lili Milani illustrating the cover of this week’s issue.